We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DOJ Subpoenas Mylan Over Pricing of Antibiotic Doxycycline
DOJ Subpoenas Mylan Over Pricing of Antibiotic Doxycycline
Amid increased scrutiny over drug pricing, Mylan has been hit with a subpoena from the antitrust division of the Department of Justice over pricing of its 50-year-old antibiotic doxycycline, the drugmaker revealed in an SEC filing.